Skip to main content
Top
Published in: Endocrine 3/2016

01-09-2016 | Original Article

Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer

Authors: Abbas Ali Tam, Didem Özdemir, Neslihan Çuhacı, Hüsniye Başer, Cevdet Aydın, Aylin Kılıç Yazgan, Reyhan Ersoy, Bekir Çakır

Published in: Endocrine | Issue 3/2016

Login to get access

Abstract

Tumor multifocality is not an unusual finding in papillary thyroid carcinoma (PTC), but its clinical significance is controversial. In this study, we aimed to evaluate impact of multifocality, tumor number, and total tumor diameter on clinicopathological features of PTC. Medical records of 912 patients who underwent thyroidectomy and diagnosed with PTC were reviewed retrospectively. Patients were grouped into four according to number of tumoral foci: N1 (1 focus), N2 (2 foci), N3 (3 foci), and N4 (≥4 foci). The diameter of the largest tumor was considered the primary tumor diameter (PTD), and total tumor diameter (TTD) was calculated as the sum of the maximal diameter of each lesion in multicentric tumors. Patients were further classified into subgroups according to PTD and TTD. Multifocal PTC was found in 308 (33.8 %) patients. Capsular invasion, extrathyroidal extension, and lymph node metastasis were significantly higher in patients with multifocal tumors compared to patients with unifocal PTC. As the number of tumor increased, extrathyroidal extension and lymph node metastasis also increased (p = 0.034 and p = 0.004, respectively). The risk of lymph node metastasis was 2.287 (OR = 2.287, p = 0.036) times higher in N3 and 3.449 (OR = 3.449, p = 0.001) times higher in N4 compared to N1. Capsular invasion, extrathyroidal extension, and lymph node metastasis were significantly higher in multifocal patients with PTD ≤10 mm and TTD >10 mm than unifocal patients with tumor diameter ≤10 mm (p < 0.001, p < 0.001 and p = 0.001, respectively). There was no significant difference in terms of these parameters in multifocal patients with PTD ≤10 mm and TTD >10 mm and unifocal patients with tumor diameter >10 mm. In this study, increased tumor number was associated with higher rates of capsular invasion, extrathyroidal extension, and lymph node metastasis. In a patient with multifocal papillary microcarcinoma, TTD >10 mm confers a similar risk of aggressive histopathological behavior with unifocal PTC greater than 10 mm.
Literature
1.
go back to reference Y. Ito, M. Fukushima, M. Kihara, Y. Takamura, K. Kobayashi, A. Miya, A. Miyauchi, Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size. Endocr. J. 59, 457–464 (2012)CrossRefPubMed Y. Ito, M. Fukushima, M. Kihara, Y. Takamura, K. Kobayashi, A. Miya, A. Miyauchi, Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size. Endocr. J. 59, 457–464 (2012)CrossRefPubMed
2.
go back to reference K.J. Kim, S.M. Kim, Y.S. Lee, W.Y. Chung, H.S. Chang, C.S. Park, Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2309 consecutive patients. Ann. Surg. Oncol. 22, 125–131 (2015)CrossRefPubMed K.J. Kim, S.M. Kim, Y.S. Lee, W.Y. Chung, H.S. Chang, C.S. Park, Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2309 consecutive patients. Ann. Surg. Oncol. 22, 125–131 (2015)CrossRefPubMed
3.
go back to reference M. Iacobone, S. Jansson, M. Barczynski, P. Goretzki, Multifocal papillary thyroid carcinoma: a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch. Surg. 399, 141–154 (2014)CrossRefPubMed M. Iacobone, S. Jansson, M. Barczynski, P. Goretzki, Multifocal papillary thyroid carcinoma: a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch. Surg. 399, 141–154 (2014)CrossRefPubMed
4.
5.
go back to reference H.J. Kim, H.K. Park, D.W. Byun, K. Suh, M.H. Yoo, Y.K. Min, S.W. Kim, J.H. Chung, Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma. Head Neck 37, 650–654 (2015)CrossRefPubMed H.J. Kim, H.K. Park, D.W. Byun, K. Suh, M.H. Yoo, Y.K. Min, S.W. Kim, J.H. Chung, Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma. Head Neck 37, 650–654 (2015)CrossRefPubMed
6.
go back to reference A. Al Afif, B.A. Williams, M.H. Rigby, M.J. Bullock, S.M. Taylor, J. Trites, R.D. Hart, Multifocal papillary thyroid cancer increases the risk of central lymph node metastasis. Thyroid 25, 1008–1012 (2015)CrossRefPubMed A. Al Afif, B.A. Williams, M.H. Rigby, M.J. Bullock, S.M. Taylor, J. Trites, R.D. Hart, Multifocal papillary thyroid cancer increases the risk of central lymph node metastasis. Thyroid 25, 1008–1012 (2015)CrossRefPubMed
7.
go back to reference J.S. Pyo, J.H. Sohn, G. Kang, D.H. Kim, J. Yun, Total surface area is useful for differentiating between aggressive and favorable multifocal papillary thyroid carcinomas. Yonsei. Med. J. 56, 355–361 (2015)CrossRefPubMedPubMedCentral J.S. Pyo, J.H. Sohn, G. Kang, D.H. Kim, J. Yun, Total surface area is useful for differentiating between aggressive and favorable multifocal papillary thyroid carcinomas. Yonsei. Med. J. 56, 355–361 (2015)CrossRefPubMedPubMedCentral
8.
go back to reference H.J. Kim, S.Y. Sohn, H.W. Jang, S.W. Kim, J.H. Chung, Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J. Surg. 37, 376–384 (2013)CrossRefPubMed H.J. Kim, S.Y. Sohn, H.W. Jang, S.W. Kim, J.H. Chung, Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J. Surg. 37, 376–384 (2013)CrossRefPubMed
9.
go back to reference N. Qu, L. Zhang, Q.H. Ji, Y.X. Zhu, Z.Y. Wang, Q. Shen, Y. Wang, D.S. Li, Number of tumor foci predicts prognosis in papillary thyroid cancer. BMC Cancer 14, 914 (2014)CrossRefPubMedPubMedCentral N. Qu, L. Zhang, Q.H. Ji, Y.X. Zhu, Z.Y. Wang, Q. Shen, Y. Wang, D.S. Li, Number of tumor foci predicts prognosis in papillary thyroid cancer. BMC Cancer 14, 914 (2014)CrossRefPubMedPubMedCentral
10.
go back to reference D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, S.I. Sherman, R.M. Tuttle, Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16, 109–142 (2006)CrossRefPubMed D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, S.I. Sherman, R.M. Tuttle, Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16, 109–142 (2006)CrossRefPubMed
11.
go back to reference F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J.W. Smit, W. Wiersinga, European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787–803 (2006)CrossRefPubMed F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J.W. Smit, W. Wiersinga, European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787–803 (2006)CrossRefPubMed
12.
go back to reference J.D. Lin, T.C. Chao, C. Hsueh, S.F. Kuo, High recurrent rate of multicentric papillary thyroid carcinoma. Ann. Surg. Oncol. 16, 2609–2616 (2009)CrossRefPubMed J.D. Lin, T.C. Chao, C. Hsueh, S.F. Kuo, High recurrent rate of multicentric papillary thyroid carcinoma. Ann. Surg. Oncol. 16, 2609–2616 (2009)CrossRefPubMed
13.
go back to reference D.W. Hosmer, S. Lemeshow, R.X. Sturdivant, Applied logistic regression, 3rd edn. (Wiley, New York, 2013)CrossRef D.W. Hosmer, S. Lemeshow, R.X. Sturdivant, Applied logistic regression, 3rd edn. (Wiley, New York, 2013)CrossRef
14.
15.
go back to reference S.F. Kuo, S.F. Lin, T.C. Chao, C. Hsueh, K.J. Lin, J.D. Lin, Prognosis of multifocal papillary thyroid carcinoma. Int. J. Endocrinol. 2013, 809382 (2013)CrossRefPubMedPubMedCentral S.F. Kuo, S.F. Lin, T.C. Chao, C. Hsueh, K.J. Lin, J.D. Lin, Prognosis of multifocal papillary thyroid carcinoma. Int. J. Endocrinol. 2013, 809382 (2013)CrossRefPubMedPubMedCentral
16.
go back to reference B.H. Lang, C.Y. Lo, W.F. Chan, K.Y. Lam, K.Y. Wan, Staging systems for papillary thyroid carcinoma: a review and comparison. Ann. Surg. 245, 366–378 (2007)CrossRefPubMedPubMedCentral B.H. Lang, C.Y. Lo, W.F. Chan, K.Y. Lam, K.Y. Wan, Staging systems for papillary thyroid carcinoma: a review and comparison. Ann. Surg. 245, 366–378 (2007)CrossRefPubMedPubMedCentral
17.
go back to reference S.B. Edge, American joint committee on cancer: AJCC cancer staging manual, 7th edn. (Springer, New York, 2010) S.B. Edge, American joint committee on cancer: AJCC cancer staging manual, 7th edn. (Springer, New York, 2010)
18.
go back to reference W. Wang, H. Wang, X. Teng, H. Wang, C. Mao, R. Teng, W. Zhao, J. Cao, TJ 3rd Fahey, L Teng, Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas. Hum. Pathol. 41, 1299–1309 (2010)CrossRefPubMed W. Wang, H. Wang, X. Teng, H. Wang, C. Mao, R. Teng, W. Zhao, J. Cao, TJ 3rd Fahey, L Teng, Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas. Hum. Pathol. 41, 1299–1309 (2010)CrossRefPubMed
19.
go back to reference T.M. Shattuck, W.H. Westra, P.W. Ladenson, A. Arnold, Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N. Engl. J. Med. 352, 2406–2412 (2005)CrossRefPubMed T.M. Shattuck, W.H. Westra, P.W. Ladenson, A. Arnold, Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N. Engl. J. Med. 352, 2406–2412 (2005)CrossRefPubMed
20.
go back to reference M. Bansal, M. Gandhi, R.L. Ferris, M.N. Nikiforova, L. Yip, S. Carty, Y. Nikiforov, Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma. Am. J. Surg. Pathol. 37, 1586–1591 (2013)CrossRefPubMed M. Bansal, M. Gandhi, R.L. Ferris, M.N. Nikiforova, L. Yip, S. Carty, Y. Nikiforov, Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma. Am. J. Surg. Pathol. 37, 1586–1591 (2013)CrossRefPubMed
21.
go back to reference G. Tallini, D. Biase, C. Durante, G. Acquaviva, M. Bisceglia, R. Bruno, M.L.B. Reggiani, G.P. Casadei, G. Costante, N. Cremonini, L. Lamartina, D. Meringolo, F. Nardi, A. Pession, K.J. Rhoden, G. Ronga, M. Torlontano, A. Verrienti, M. Visani, S. Filetti, BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study. Mod. Pathol. 28, 1343–1359 (2015)CrossRefPubMed G. Tallini, D. Biase, C. Durante, G. Acquaviva, M. Bisceglia, R. Bruno, M.L.B. Reggiani, G.P. Casadei, G. Costante, N. Cremonini, L. Lamartina, D. Meringolo, F. Nardi, A. Pession, K.J. Rhoden, G. Ronga, M. Torlontano, A. Verrienti, M. Visani, S. Filetti, BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study. Mod. Pathol. 28, 1343–1359 (2015)CrossRefPubMed
22.
go back to reference Q. Zhao, J. Ming, C. Liu, L. Shi, X. Xu, X. Nie, T. Huang, Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann. Surg. Oncol. 20, 746–752 (2013)CrossRefPubMed Q. Zhao, J. Ming, C. Liu, L. Shi, X. Xu, X. Nie, T. Huang, Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann. Surg. Oncol. 20, 746–752 (2013)CrossRefPubMed
23.
go back to reference H. Qu, G.R. Sun, Y. Liu, Q.S. He, Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Clin. Endocrinol. 83, 124–132 (2015)CrossRef H. Qu, G.R. Sun, Y. Liu, Q.S. He, Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Clin. Endocrinol. 83, 124–132 (2015)CrossRef
24.
go back to reference M. Mustafa, T. Kuwert, K. Weber, P. Knesewitsch, T. Negele, A. Haug, R. Linke, P. Bartenstein, D. Schmidt, Regional lymph node involvement in T1 papillary thyroid carcinoma: a bicentric prospective SPECT/CT study. Eur. J. Nucl. Med. Mol. Imaging 37, 1462–1466 (2010)CrossRefPubMed M. Mustafa, T. Kuwert, K. Weber, P. Knesewitsch, T. Negele, A. Haug, R. Linke, P. Bartenstein, D. Schmidt, Regional lymph node involvement in T1 papillary thyroid carcinoma: a bicentric prospective SPECT/CT study. Eur. J. Nucl. Med. Mol. Imaging 37, 1462–1466 (2010)CrossRefPubMed
Metadata
Title
Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer
Authors
Abbas Ali Tam
Didem Özdemir
Neslihan Çuhacı
Hüsniye Başer
Cevdet Aydın
Aylin Kılıç Yazgan
Reyhan Ersoy
Bekir Çakır
Publication date
01-09-2016
Publisher
Springer US
Published in
Endocrine / Issue 3/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-0955-0

Other articles of this Issue 3/2016

Endocrine 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.